ophthalmology

Regeneron booth at AACR 2026

Biotech

Regeneron ends eye disease trial following safety review

The Titan study tested REGN7041, an anti-CD3 monoclonal antibody, in patients with inflammation of the uvea, the eye’s middle layer.

Darren Incorvaia Aug 17, 2026 2:30pm

Closeup of blue eye on black background

Bausch + Lomb gives up on glaucoma eye drop hopeful after fail

Jul 10, 2026 7:31am

horse horse riding lasso man on horse in shadows

Ollin hauls in $330M for Vabysmo challenger's ph. 3 gauntlet

Jun 24, 2026 7:00am

eyeball eye disease eyelash eyes

Ocugen’s CEO wants to bring gene therapy to the masses

Apr 16, 2026 9:00am

Closeup of blue eye on black background

Viridian’s Tepezza rival scores ph. 3 win, but investors unsure

Mar 30, 2026 10:11am

Closeup of blue eye on black background

Innovent eyes China approval after matching Eylea in phase 3

Mar 24, 2026 6:00am